Governance
The GIP
Genopole is a groupement d’intérêt public (GIP), a form of public-private partnership for missions of public interest. It functions thanks to the steadfast commitment of its 12 members. Genopole is built upon a solid foundation of decision-making bodies and scientific strategy committees that empower its ability to successfully carry out its missions.
The biocluster benefits from the unwavering support of public institutions, notably the French State and the Île-de-France Regional Council. These precious partners provide consequential funding, which enables investments in and the operation of the shared-use technological platforms, and, in turn, innovation and cutting-edge research.
GIP Genopole General Meeting
The General Meeting is composed of representatives from each member institution. It is the GIP’s administrative body and makes all decisions concerning it: strategic orientations, annual program, budget approval, etc. The General Meeting carries out elections for the presidential and vice-presidential posts and also deliberates nominations to the Committee for Science, Innovation and Industry (CSII). In 2023, the Essonne CCI joined GIP Genopole as an associate member.
Stéphane BEAUDET
President, General Meeting
Laure DARCOS
Vice-president, General Meeting
Committee for Science, Innovation and Industry (CSII)
The CSII, headed by Emmanuelle Quilès, is composed of qualified persons with particular competencies in Genopole’s fields of activity. Its members are approved by the General Meeting. The role of the CSII is to provide the General Meeting with opinions and recommendations on the scientific and industrial orientations of GIP Genopole. A seat on the CSII is accorded intuiti personae; the members act in strict independence of their affiliations.
Emmanuelle QUILÈS
President, Committee for Science, Innovation and Industry
An engaged team
GIP Genopole benefits from multidisciplinary teams committed to creating a fertile environment for research and innovation.
Our missions
Cultivate ties between public and private research.
Accelerate the growth and development of biotech businesses.
Whether focused on administrative management, research and business, infrastructures and platforms, international affairs or communication, the GIP Genopole teams are all driven by a shared passion: bring progress to life sciences and enable innovation.
With their commitment, energy and renowned know-how, these teams have made that passion an objective to be reached via their actions to accompany and develop the biocluster’s laboratories, start-ups and businesses.
Genopole’s scientific committee
In 2023, the GIP established a scientific committee whose missions are to proactively respond to the needs of public laboratories and private entities and create synergies while constantly adapting and improving its initiatives. Composed of representatives from every biocluster laboratory, the committee builds upon their valuable, collective expertise to guide deliberations toward novel strategic and innovative scientific positions.
